Prostate Cancer Trial, Recruiting NCT06072911 Sponsor: University of Alberta Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06072911
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with prostate cancer at any stage (stage I to IV)
  • People who are scheduled to have surgery to remove the prostate (any surgical method)
  • People who have no restrictions on doing at least light physical activity, based on a standard health screening questionnaire called the PAR-Q+
  • People who can speak and understand English
  • People who are 18 years of age or older
  • For the optional exercise part of the trial: people who are willing and able to commit to a 12-week program

Who may not be able to join:

  • People who have medical conditions that could affect bladder control, such as neurological (nerve or brain) diseases
  • People who have any medical reasons that would make exercise testing or training unsafe for them
  • People who have changed medication used to help with bladder leakage within the past 6 months (for example, a medicine called Myrbetric)
  • People who do not have regular access to the internet and a smartphone, tablet, or computer — either at home or at a community centre
  • People who are already working with a pelvic floor physiotherapist in their community on a pelvic floor exercise program

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nathan Hoy, MD, University of Alberta

Phone: 780-492-6007

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 February 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Completion Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov